NCT04452864

Brief Summary

Today the therapy options for dementia due to Alzheimer's disease (AD) are limited. One recommended intervention is cognitive stimulation. We try to develop serious games as a further treatment option, also usable in pre-dementia as well as early stages of dementia and for a long period of time. The main objective of this study is to test, if the computerized-cognitive training (CCT) is able to improve the performance in a score quantifying an "AD-specific" component score. Additionally, the neurobiological effects of the training are investigated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
162

participants targeted

Target at P50-P75 for not_applicable alzheimer-disease

Timeline
Completed

Started Jul 2020

Longer than P75 for not_applicable alzheimer-disease

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 24, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 1, 2020

Completed
Same day until next milestone

Study Start

First participant enrolled

July 1, 2020

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 9, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2024

Completed
Last Updated

January 10, 2025

Status Verified

January 1, 2025

Enrollment Period

4 years

First QC Date

June 24, 2020

Last Update Submit

January 8, 2025

Conditions

Keywords

Alzheimer DiseaseDementiaMild Cognitive ImpairmentCognitive TrainingSerious Games

Outcome Measures

Primary Outcomes (1)

  • Change in AD specific component score

    The outcome is quantified by an AD component score including measures of EM (auditory verbal learning), SM (verbal fluency, naming task) and spatial abilities (Rey-Osterrieth complex figure test). These scores will be assessed four times, before the training as well as after three, six and nine months by tablet-based cognitive tests. A short follow-up assessment will be performed after a total of 12 months which does not include primary outcome measure.

    The primary endpoint will be assessed four times, with breaks of three months in between. Primary outcome will be assessed up to 9 months.

Secondary Outcomes (1)

  • MRI functional and structural

    Secondary endpoints will be assessed two to four times, depending on the study arm, as MRI assessments are not always performed after six and nine months.

Study Arms (3)

Study Intervention

EXPERIMENTAL

The study intervention consists of a tablet-based cognitive training, targeting the cognitive domains mostly affected by AD. This training will be performed for three months (each day for 20 minutes). After three months this group will continue the training at home for six months and meet monthly for group sessions (i.e. booster sessions) on site.

Device: Computerized Cognitive Training

Active Control Group

ACTIVE COMPARATOR

This control study arm will watch documentaries at home for three months (each day for 20 minutes) , instead of performing the CCT and serve as active control group. This group will also train with the CCT tasks after these three months.

Device: Documentaries with delayed Computerized Cognitive Training

Wait-List Control

OTHER

This control study arm will start with the CCT with a delay of three months and serve as wait-list control group.

Device: Computerized Cognitive Training

Interventions

The study intervention consists of a tablet-based cognitive training, targeting the cognitive domains mostly affected by Alzheimer Disease.

Study InterventionWait-List Control

The active control group watches documentaries for three months before starting with the CCT.

Active Control Group

Eligibility Criteria

Age60 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of Alzheimer's Disease
  • Patients with increased risk for developing dementia
  • Must be able to give their consent

You may not qualify if:

  • Contra-indications for MRI scanning
  • Substance abuse
  • Severe medical conditions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University Hospital of Old Age Psychiatry and Psychotherapy

Bern, 3000, Switzerland

Location

Memory Clinic Zentralschweiz

Lucerne, 6000, Switzerland

Location

Related Publications (1)

  • Brill E, Krebs C, Falkner M, Peter J, Henke K, Zust M, Minkova L, Brem AK, Kloppel S. Can a serious game-based cognitive training attenuate cognitive decline related to Alzheimer's disease? Protocol for a randomized controlled trial. BMC Psychiatry. 2022 Aug 12;22(1):552. doi: 10.1186/s12888-022-04131-7.

    PMID: 35962371BACKGROUND

MeSH Terms

Conditions

Alzheimer DiseaseDementiaCognitive Dysfunction

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersCognition Disorders

Study Officials

  • Stefan Klöppel, Prof. Dr.

    University of Bern

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to one of three study arms and conduct a Computerized Cognitive Training (CCT) at home (daily) and on site (weekly) for 10 weeks. Before and after the CCT, neuropsychological assessments will be conducted.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 24, 2020

First Posted

July 1, 2020

Study Start

July 1, 2020

Primary Completion

July 9, 2024

Study Completion

October 31, 2024

Last Updated

January 10, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will share

All IPD that underlie results in a publication will be published pseudonymized in a open access data base

Time Frame
IPD and any additional material will be available when data collection and analysis is completed Items will be retained for the lifetime of the repository (at least 20years)
Access Criteria
According to SNF Guidelines IPD will be published in a open access data base

Locations